Helen S. Kim
InvestorSenior Managing Director at Vida Ventures
Find your path to Helen
Sign up to see every warm intro you have to Helen
- Paths you didn't know you had: your email and LinkedIn already hold routes to Helen. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
About
Biotech executive with 35+ years in leadership roles, previously a Partner at The Column Group and EVP of Business Development at Kite Pharma. She serves on several biotech boards.
Contact· self-published, not guessed
Invests in
BiotechHealthtech
Deals · 2
Aktis OncologyBoard seat
via Vida Ventures · filed Oct 2024 · $175M raise
IconOVir BioBoard seat
via Vida Ventures · filed Jun 2024 · $20.2M raise
Attribution from SEC filings, press coverage, and firm rosters.
Other disclosed investments
Board seats
Per SEC Form D filings.
Colleagues at Vida Ventures
Frequently asked questions
- Who is Helen S. Kim?
- Biotech executive with 35+ years in leadership roles, previously a Partner at The Column Group and EVP of Business Development at Kite Pharma. She serves on several biotech boards.
- Where does Helen S. Kim work?
- Helen S. Kim is Senior Managing Director at Vida Ventures.
- What does Helen S. Kim invest in?
- Helen S. Kim invests in Biotech, Healthtech.
- What boards does Helen S. Kim sit on?
- Helen S. Kim holds tracked board seats at A2 Biotherapeutics, Aktis Oncology, IconOVir Bio, ReCode Therapeutics.
About this profile. Compiled from public sources — Vida Ventures's own website, regulatory filings and public professional profiles — and summarised by Fundraising Fox; every fact is kept with where it came from. Spotted an error, or would rather not be listed? Email privacy@fundraisingfox.com · How we build profiles · Your rights








